Search clinical trials for: Fluticasone Propionate 0.05 MG/ACTUAT
Total 1040 results
-
MEDA Pharma GmbH & Co. KGCompleted
-
Aileron Therapeutics, Inc.Completed
-
Integro TheranosticsRecruitingBreast Cancer | DCIS | Invasive Duct Carcinoma of BreastUnited States
-
Padagis LLCCompleted
-
Andrew J. Armstrong, MDCompletedProstate CancerUnited States
-
Padagis LLCCompleted
-
Research in Real-Life LtdTeva Branded Pharmaceutical Products R&D, Inc.Completed
-
University of FloridaFood and Drug Administration (FDA)Completed
-
AsclepiX Therapeutics, Inc.TerminatedDiabetic Macular Edema (DME)United States
-
AsclepiX Therapeutics, Inc.TerminatedNeovascular Age-Related Macular Degeneration (nAMD)United States
-
Cara Therapeutics, Inc.CompletedPruritus | Atopic DermatitisUnited States, Canada
-
GlaxoSmithKlineCompleted
-
Garlapati KomaliUnknown
-
KBP BiosciencesWorldwide Clinical TrialsCompletedHypertension | Chronic Kidney DiseasesUnited States
-
Novo Nordisk A/SCompleted
-
Duramed ResearchCompletedDysmenorrheaUnited States
-
Galderma R&DCompleted
-
Fougera Pharmaceuticals Inc.Completed
-
Cara Therapeutics, Inc.Terminated
-
Ceragenix PharmaceuticalsCompleted
-
Academisch Medisch Centrum - Universiteit van Amsterdam...UnknownPatients With Active Non-segmental Vitiligo. | Evaluation of the Efficacy of UVB and Fluticason Proprionate 0.05% | Cream Compared to NB-UVB Alone in Patients With Non-segmental VitiligoNetherlands
-
Dermatology Consulting Services, PLLCCompletedPsoriasis VulgarisUnited States
-
Netherlands Institute for Pigment DisordersWithdrawn
-
Imperial College LondonCompleted
-
Padagis LLCCompleted
-
ReveraGen BioPharma, Inc.University of Pittsburgh; Cooperative International Neuromuscular Research...CompletedDuchenne Muscular DystrophyUnited States, Canada, United Kingdom, Sweden, Australia, Israel
-
Teva Pharmaceuticals USATerminatedSeasonal Allergic RhinitisUnited States
-
ReveraGen BioPharma, Inc.National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) and other collaboratorsCompletedDuchenne Muscular DystrophyUnited States, Canada, United Kingdom, Sweden, Australia, Israel
-
ReveraGen BioPharma, Inc.National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) and other collaboratorsCompletedDuchenne Muscular DystrophyUnited States, Canada, United Kingdom, Sweden, Australia, Israel
-
PfizerCompletedPulmonary Disease, Chronic ObstructiveUnited Kingdom
-
Cara Therapeutics, Inc.Completed
-
GlaxoSmithKlineCompleted
-
Cara Therapeutics, Inc.CompletedChronic Kidney Diseases | PruritusUnited States
-
GlaxoSmithKlineCompletedAsthmaUnited States, Argentina, Philippines, Canada, Brazil
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveUnited Kingdom
-
BioMarin PharmaceuticalCompletedPhenylketonuriaUnited States
-
Padagis LLCCompleted
-
Boehringer IngelheimCompletedAsthmaUnited States, Australia, Canada, Colombia, Korea, Republic of, Mexico, New Zealand, Peru, Philippines, Taiwan
-
Kari Nadeau, MD, PhDUniversity of Chicago; Stanford University; Children's Hospital Medical Center... and other collaboratorsRecruitingEczema | Atopic Dermatitis | Atopic Dermatitis Eczema | Eczema, InfantileUnited States, United Kingdom
-
Promius Pharma, LLCCompleted
-
AllerganCompletedLong-Term Safety of Bimatoprost Ophthalmic Solution in Patients With Glaucoma or Ocular HypertensionOcular Hypertension | GlaucomaSpain, France, Belgium, Israel, United Kingdom, Poland, Italy, Czechia, Germany, Hungary
-
Bausch & Lomb IncorporatedCompleted
-
Skin Sciences, PLLCUnknownPlaque PsoriasisUnited States
-
Galderma R&DCompleted
-
Novartis PharmaceuticalsTerminated
-
DeyCompletedChronic Obstructive Pulmonary DiseaseUnited States
-
Hansa Biopharma ABUniversity College London HospitalsTerminatedPurpura, Thrombotic ThrombocytopenicUnited Kingdom
-
Duramed ResearchCompletedContraceptionUnited States